Zobrazeno 1 - 10
of 128
pro vyhledávání: '"WOLFGANG EISTERER"'
Autor:
Yawen Dong, Jonas Santol, Birgit Gruenberger, Alfred Lenauer, Friedrich Laengle, Josef Thaler, Gudrun Piringer, Wolfgang Eisterer, Angela Djanani, Judith Stift, Thomas Gruenberger
Publikováno v:
Cancers, Vol 16, Iss 5, p 857 (2024)
In 2007, the ASSO-LM1 trial, a multicenter prospective study, was initiated to investigate the resectability (R0) rate following preoperative combination therapy with XELOX and bevacizumab in patients with potentially resectable colorectal liver meta
Externí odkaz:
https://doaj.org/article/3370f126caab4bdab811a651fcdf8d0a
Autor:
Bernd Kasper, Daniel Pink, Christian Rothermundt, Stephan Richter, Marinela Augustin, Attila Kollar, Annegret Kunitz, Wolfgang Eisterer, Verena Gaidzik, Thomas Brodowicz, Gerlinde Egerer, Peter Reichardt, Peter Hohenberger, Markus K. Schuler
Publikováno v:
Cancers, Vol 16, Iss 3, p 558 (2024)
E-TRAB was a non-interventional, prospective trial investigating the feasibility and predictive value of geriatric assessments (GA) in older STS patients treated with trabectedin as first-line therapy. Primary endpoints were overall survival (OS), qu
Externí odkaz:
https://doaj.org/article/d20f837008d84c16b2c67a7b22f04c4c
Autor:
Hossein Taghizadeh, Angela Djanani, Wolfgang Eisterer, Armin Gerger, Birgit Gruenberger, Thomas Gruenberger, Holger Rumpold, Lukas Weiss, Thomas Winder, Ewald Wöll, Gerald W. Prager
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Locally advanced or metastatic cholangiocarcinoma is an aggressive carcinoma with a dismal prognosis. For the first-line treatment of locally advanced or metastatic cholangiocarcinoma, cisplatin/gemcitabine has been the standard of care for more than
Externí odkaz:
https://doaj.org/article/ac2eb60400d44723bdbe5729355db3ab
Autor:
Gudrun Piringer, Thomas Gruenberger, Josef Thaler, Irene Kührer, Klaus Kaczirek, Friedrich Längle, Istvan Viragos-Toth, Arno Amann, Wolfgang Eisterer, Reinhold Függer, Johannes Andel, Angelika Pichler, Judith Stift, Lidija Sölkner, Michael Gnant, Dietmar Öfner
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundTwenty percent of colorectal cancer liver metastases (CLMs) are initially resectable with a 5-year survival rate of 25%–40%. Perioperative folinic acid, 5-fluorouracil, oxaliplatin (FOLFOX) increases progression-free survival (PFS). In ad
Externí odkaz:
https://doaj.org/article/a086fc5f438c457e89f61feead205633
Autor:
Verena Schlintl, Florian Huemer, Gabriel Rinnerthaler, Thomas Melchardt, Thomas Winder, Patrick Reimann, Jakob Riedl, Arno Amann, Wolfgang Eisterer, Franz Romeder, Gudrun Piringer, Aysegül Ilhan-Mutlu, Ewald Wöll, Richard Greil, Lukas Weiss
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Safety and efficacy of immune checkpoint inhibitors in advanced gastric or gastroesophageal junction (GEJ) cancer could be demonstrated in predominantly Asian cohorts, whereas data in Western patients outside of clinical trials ar
Externí odkaz:
https://doaj.org/article/4eb806de63a04d64920beb1c085feb6d
Autor:
Martin Fehr, Hanne Hawle, Stefanie Hayoz, Peter Thuss-Patience, Sabina Schacher, Jorge Riera Knorrenschild, Donat Dürr, Wolfram T. Knoefel, Holger Rumpold, Michael Bitzer, Martin Zweifel, Panagiotis Samaras, Ulrich Mey, Marc Küng, Ralph Winterhalder, Wolfgang Eisterer, Viviane Hess, Marie-Aline Gérard, Arnoud Templeton, Michael Stahl, Thomas Ruhstaller, for the Swiss Group for Clinical Cancer Research (SAKK), the German Esophageal Cancer Study Group, the Austrian Arbeitsgemeinschaft Medikamentöse Tumortherapie (AGMT), the Fédération Francophone de Cancérologie Digestive (FFCD) / Fédération de Recherche en Chirurgie (FRENCH)
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background High rates of venous thromboembolic events (VTEs), mainly in advanced disease, are reported for patients with cancer of the upper gastrointestinal tract (stomach, pancreas) and for treatment with cisplatin. Methods Exploratory ana
Externí odkaz:
https://doaj.org/article/0081a584ac4248f78e6831be4adafd73
Autor:
Jakob Michael Riedl, Florian Posch, Gerald Prager, Wolfgang Eisterer, Leopold Oehler, Thamer Sliwa, Klaus Wilthoner, Andreas Petzer, Petra Pichler, Eva Hubmann, Thomas Winder, Sonja Burgstaller, Markus Korger, Johannes Andel, Richard Greil, Hans-Joerg Neumann, Martin Pecherstorfer, Kathrin Philipp-Abbrederis, Angela Djanani, Birgit Gruenberger, Friedrich Laengle, Ewald Wöll, Armin Gerger
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Background: The pretreatment De Ritis ratio [aspartate transaminase (AST)/alanine transaminase (ALT)] has been shown to be an adverse prognostic marker in various cancer entities. However, its relevance to advanced pancreatic ductal adenocarcinoma (P
Externí odkaz:
https://doaj.org/article/6ae640a6f55e4ed2b9869593c943f051
Autor:
Werner Scheithauer, Paul Martin Putora, Birgit Grünberger, Wolfgang Eisterer, Ewald Wöll, Gerald Prager, Renate Schaberl-Moser, Richard Greil, Markus Glatzer
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 12 (2019)
Background: The management of patients with metastatic pancreatic cancer (mPC) is challenging, and the optimal treatment strategy is debated among experts. In an attempt to identify treatment decision criteria and to investigate variations in the fir
Externí odkaz:
https://doaj.org/article/aab23eb60b284a1a8f0e244c78fc982d
Autor:
Florian Huemer, Lukas Weiss, Peter Regitnig, Thomas Winder, Bernd Hartmann, Josef Thaler, Gudrun Piringer, Clemens A. Schmitt, Wolfgang Eisterer, Hannes Gänzer, Alois Wüstner, Johannes Andel, Björn Jagdt, Hanno Ulmer, Richard Greil, Ewald Wöll
Publikováno v:
Journal of Clinical Medicine, Vol 9, Iss 4, p 935 (2020)
Trastuzumab in combination with a platinum and fluorouracil is the treatment of choice for patients with advanced human epidermal growth factor receptor 2 (HER2) positive gastric cancer and gastroesophageal junction (GEJ) cancer. Pathological assessm
Externí odkaz:
https://doaj.org/article/0f0f0d7ef42e47bcb5b3e0ac869c7292
Autor:
Armin, Gerger, Wolfgang, Eisterer, Stefan, Fuxius, Sara, Bastian, Dieter, Koeberle, Manfred, Welslau, Dilara Akhoundova, Sanoyan, Christian, Maas, Jens, Uhlig, Klaus, Fenchel, Richard, Greil, Eyck, VON DER Heyde, Gaëlle Rhyner, Agocs, Rudolf, Weide, Monika, Schwager, Frank, Reichenbach, Dominik Paul, Modest, Ralph, Fritsch
Publikováno v:
Anticancer research. 42(10)
Metastatic colorectal cancer (mCRC) is a heterogeneous disease with distinct molecular subtypes. The BRAFAnonymized data from BRAFForty-two patients were eligible for analysis (mean age 62.1 years, 47.6% female). At initial diagnosis, 20 patients (47